Lantz Financial’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.7M Buy
18,566
+95
+0.5% +$8.31K 0.31% 88
2026
Q1
$1.57M Sell
18,471
-883
-5% -$78.7K 0.33% 83
2025
Q4
$1.53M Buy
19,354
+149
+0.8% +$11.7K 0.32% 85
2025
Q3
$1.54M Buy
19,205
+3
+0% +$256 0.34% 85
2025
Q2
$1.75M Sell
19,202
-83
-0.4% -$7.58K 0.44% 70
2025
Q1
$1.81M Sell
19,285
-855
-4% -$76.6K 0.49% 60
2024
Q4
$1.83M Buy
20,140
+122
+0.6% +$11.6K 0.49% 60
2024
Q3
$2.08M Buy
20,018
+24
+0.1% +$2.45K 0.56% 54
2024
Q2
$1.94M Sell
19,994
-56
-0.3% -$5.17K 0.6% 49
2024
Q1
$1.81M Buy
20,050
+135
+0.7% +$11.4K 0.58% 54
2023
Q4
$1.59M Buy
19,915
+801
+4% +$60.2K 0.57% 51
2023
Q3
$1.36M Sell
19,114
-292
-2% -$21.8K 0.54% 54
2023
Q2
$1.5M Sell
19,406
-38
-0.2% -$2.94K 0.59% 53
2023
Q1
$1.46M Sell
19,444
-145
-0.7% -$10.8K 0.61% 50
2022
Q4
$1.54M Buy
19,589
+317
+2% +$23.8K 0.7% 39
2022
Q3
$1.35M Buy
19,272
+58
+0.3% +$4.55K 0.7% 39
2022
Q2
$1.54M Buy
19,214
+75
+0.4% +$5.87K 0.7% 40
2022
Q1
$1.45M Buy
19,139
+287
+2% +$22.7K 0.59% 52
2021
Q4
$1.61M Buy
18,852
+778
+4% +$60.8K 0.74% 40
2021
Q3
$1.37M Buy
18,074
+378
+2% +$30K 0.7% 43
2021
Q2
$1.44M Buy
17,696
+27
+0.2% +$2.21K 0.74% 40
2021
Q1
$1.39M Buy
17,669
+125
+0.7% +$9.8K 0.79% 38
2020
Q4
$1.5M Sell
17,544
-268
-2% -$22.2K 0.94% 29
2020
Q3
$1.37M Sell
17,812
-31
-0.2% -$2.36K 0.92% 33
2020
Q2
$1.31M Sell
17,843
-425
-2% -$30.2K 0.94% 31
2020
Q1
$1.21M Sell
18,268
-827
-4% -$58.3K 0.95% 31
2019
Q4
$1.31M Buy
19,095
+220
+1% +$15K 0.78% 47
2019
Q3
$1.33M Buy
18,875
+213
+1% +$15.5K 0.9% 36
2019
Q2
$1.36M Buy
18,662
+436
+2% +$31K 0.92% 36
2019
Q1
$1.25M Buy
+18,226
New +$1.18M 0.91% 39

Other funds holding CL

Lantz Financial's CL Position: Q2 2026 in Review

Lantz Financial increased its Colgate-Palmolive (CL) stake by 0.51% in Q2 2026, buying an estimated $8.31K and bringing the position to 18,566 shares worth $1.7M. The position accounts for 0.31% of the portfolio, ranked #88.

Lantz Financial first reported a position in CL in Q1 2019 and has held it in 30 quarters since. The position peaked at $2.08M in Q3 2024. 597 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Lantz Financial held 18,566 shares of Colgate-Palmolive worth $1.7M as of Q2 2026.
  • Lantz Financial bought 95 Colgate-Palmolive shares in Q2 2026, an estimated $8.31K.
  • Colgate-Palmolive made up 0.31% of Lantz Financial's portfolio in Q2 2026, its #88 holding.
  • Lantz Financial first reported a position in Colgate-Palmolive in Q1 2019 and has held it in 30 quarters since.
  • Lantz Financial's Colgate-Palmolive position peaked at $2.08M in Q3 2024.
  • 597 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Lantz Financial's 13F filing for Q2 2026, filed 9 Jul 2026.